Alison Guzzio retweeted
Welcome to Signios Bio, where we are decoding the future of healthcare with multiomics and AI-powered bioinformatics. hubs.ly/Q03gHx_k0
#SigniosBio #Multiomics #ScienceOfSignals
Alison Guzzio retweeted
Please check out this excellent interview: longevity.technology/news/ne… In keeping with my tradition of showcasing groundbreakers that few longevists have heard of, Christian will be speaking at RAADfest (Vegas, July 10-13) which LEVF is co-organising with the CRLE this year.
Alison Guzzio retweeted
DoseMeRx is the only HITRUST CSF r2 certified Bayesian Dosing Software Platform
What is @HITRUST? The world’s most widely trusted set of information security frameworks. doseme-rx.com/news-media/art…
#healthcareIT #HealthITSolutions #HealthITStrategy
Alison Guzzio retweeted
DoseMeRx has a new vancomycin #hemodialysis (HD) model, enabling personalized dosing that reduces the necessity for multiple blood draws for #vancomycin levels!🩸 doseme-rx.com/news-media/art… Contact us to access the model & improve dosing accuracy & patient outcomes today.
Alison Guzzio retweeted
Congratulations to the members of the field hockey team for being selected 2023 Ches-Mont All-League!!!
Alison Guzzio retweeted
Join us for a deep dive into the latest guidance around flow in this upcoming #webinar with Chief Methodologist Andrew Sales and @sdtimes News Editor Jenna Barron.
Learn proven ways to make value flow without interruptions at every level.
Sign up: d2emerge7472.ac-page.com/sca…
Alison Guzzio retweeted
📣The Fierce 50 special report is here! It's a celebration of 50 remarkable individuals and organizations making waves in biopharma and healthcare. The Health Equity honorees are dedicated to breaking down barriers to care. fiercepharma.com/special-rep…
Alison Guzzio retweeted
A.C. Camargo Cancer Center utilizes DoseMe precision dosing platform to substantially reduce toxicity; achieves a 70% decrease in #acutekidneyinjury rates among #oncology #patients.
Read full article: doseme-rx.com/news-media/art…
Alison Guzzio retweeted
🚀 Exciting Half-Year Update! 🌟 From groundbreaking tech advancements to key partnerships (@googlecloud, @nvidia, @PacBio) & stellar leadership hires, our #AI-driven #drugdiscovery platform is making waves in life sciences. hubs.li/Q01-zqCt0
Alison Guzzio retweeted
Replying to @ClaireAldridge2
@ClaireAldridge2 discusses @SynBioBeta the future of #biomanufacturing in CGT, highlighting the shift towards #insilico approaches, which aim to reduce truncations, enhance read quality & improve quality of drugs. Watch 4-min video: hubs.li/Q01W0z4P0 #synbiobeta2023
Alison Guzzio retweeted
We are excited to announce the launch of FORMsightAI - our new AI-powered turnkey solution to predict bioreactor output and optimize therapy constructs to achieve ideal dose yield, safety, and cost!
Read more about it here: hubs.li/Q01PxN7B0
Alison Guzzio retweeted
Thank you Global Health & Pharma for picking @form_bio as the Best Computational Biology R&D Company of 2023 at the GHP Biotechnology Awards!
@form_bio is excited to continue building our platform to accelerate #celltherapy and #genetherapy development.
Alison Guzzio retweeted
How can the biotech industry maximize ROI given a downturn year?
At Form Bio, we are using the power of biomedical data to build simulations and optimization algorithms to reduce costs for cell and gene therapy development.
Listen to more here: hubs.li/Q01NlPt00)
Alison Guzzio retweeted
William Troy, PhD is the superstar behind the scenes who is building our computational workflows. We are amazed by his ability to build tech across multiple sectors of life science and we are excited to bring his work into the hands of customers like you.
hubs.li/Q01LZzkH0
Alison Guzzio retweeted
Great update today from the @ScaledAgile's @mdclarkin.
500 partners to help orgs adopt/succeed with #SAFe.
Over 1 million people now trained on the SAFe framework.
My analysis on how SAFe addresses challenges of delivering #agile to large enterprises coming soon!
#cio #DevOps
Alison Guzzio retweeted
This a must-attend for all Agile and SAP enthusiasts who want to unlock the full potential of transformations through the combination of SAFe® and SAP.
Register: ow.ly/yIRI50MTQAK.
Share with your peers and join SAFe, SBB and SAP in this insightful discussion! #SAFe #SAP
Alison Guzzio retweeted
Join @form_bio + @BeyondBatten for a discussion on the promise and challenges of rare disease R+D on @rarediseaseday 2023.🔬
@ClaireAldridge2 and Craig Benson will connect live Feb 28 @ 12:00pm CT on some considerations for this challenging environment. hubs.li/Q01CkHvS0
Alison Guzzio retweeted
[New on the Blog] With AI becoming central for life sciences, we thought it fitting (and fun!) to utilize creative AI tools to see what 2023 might have in store for cell and gene therapy. Hence, our guest author is none other than OpenAI's ChatGPT. hubs.li/Q01vxWYc0
Alison Guzzio retweeted
In developing next-gen biologics, and leveraging the data sets that accompany them, @1AlexanderTitus explores the future state of cross-departmental collaboration in #drugdiscovery.
We have entered a new age in #biologics development, which is undergoing a technological revolution with an increasing focus on software-dependent and data-driven results.
By @itiscolossal
#biologics #drugdiscovery #computationalscience
bioprocessonline.com/doc/bio…
Alison Guzzio retweeted
“The mission of the TiGER study is to help establish personalized medicine as the primary form of care in rheumatoid arthritis.” ~ Ron Rocca, President & CEO
Visit the #Exagen website to read more 🔗 stockmkt.info/3SCYCmu
#pharmastock #NASDAQ





















